Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Low INR to Minimize Bleeding With Mechanical Valves Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether targeting a lower international normalized ratio (INR) reduces bleeding in patients with mechanical heart valves. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: Population Health Research Institute | Conditions: Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement | Phase 3 | Status: RECRUITING